The American pharmaceutical company Pfizer agreed to pay $2.3 billion (https://www.justice.gov/opa/pr/justice-department-announces-largest-health-care-fraud-settlement-its-history) in order to settle the fraud case out of court (2009).
The world’s largest pharmaceutical manufacturer Pfizer will pay $60.2 million in fines for corruption (https://www.reuters.com/article/us-pfizer-settlement-idUSBRE8760WM20120807) two of their international “daughters” whose employees bribed officials in Russia, Kazakhstan, Bulgaria and Croatia. (2012)
US drug manufacturer Pfizer will pay a fine of $491 million (https://www.nytimes.com/2013/07/31/business/pfizer-settles-a-drug-marketing-case-for-491-million.html) to resolve a conflict with the illegal sale of pharmaceuticals by a subsidiary of Wyeth, acquired by Pfizer in 2009. (2013)
Pfizer has faced more than 3,000 lawsuits for illegal marketing of celecoxib and valdecoxib, NSAIDs that are more dangerous than older NSAIDs.
In 2004, Pfizer pleaded guilty to two crimes and paid $430 million to settle allegations of fraudulent advertising of the antiepileptic drug Neurontin (gabapentin) on an unapproved basis.
In 2010, a jury ruled that Pfizer violated federal racketeering and corruption law and must pay $142 million in damages. The jury also concluded that Pfizer has been involved in racketeering for the past 10 years.
In 2011, Japan officially suspended the use of Pfizer’s pneumonia and meningitis vaccine due to the death of four children between six months and two years of age, within three days of vaccination.
In July 2021, the company was fined £260 million for overpricing the drug hydrocortisone. Its prices have increased by more than 10,000 percent. The company paid potential competitors to keep them out of the market. And while remaining the only supplier, it increased the price of the drug.
In November 2021, with reference to regional leaders of Ventavia Research Group, which participated in the clinical trials of the Pfizer vaccine, the British scientific journal BMJ published an investigation into the irregularities during the clinical trials of the Pfizer vaccine.
“A regional executive at Ventavia Research Group, which was involved in clinical trials of Pfizer’s vaccine, told BMJ that the company had falsified data, disclosed patient identities, had insufficient training for vaccine staff, and was slow to report side effects. which arose during the third phase of testing.”
The BMJ noted that they conducted this investigation after Brooke Jackson, the former regional head of Ventavia Research Group, which helped Pfizer conduct clinical trials of the vaccine, contacted the editorial office of the publication. Jackson said she was fired in September 2020 after repeatedly reporting massive clinical trial irregularities to the company’s headquarters.
The dismissed employee prepared and submitted to the magazine a set of documents, photographs, video and audio recordings that convinced the BMJ editors that her statements were not deliberate disinformation. The British publication double-checked the information received and received other evidence that vaccine trials did not meet the standards and norms that Pfizer executives have often claimed to be adhered to.
Follow us in: Telegram